In October 2026, a study in Biogerontology reported that fruit flies kept on food containing finasteride lived shorter lives. For men, the largest randomized survival data come from a trial that followed them for up to 18 years.
The short answer: In the largest randomized trial, 18,880 men aged 55 and over took finasteride 5 mg or placebo for seven years. Fifteen-year survival was 78.0% vs 78.2%, not a statistically significant difference (Thompson et al. 2013). Observational studies are mixed. A 2026 study found shorter lives in fruit flies fed finasteride. By our rough arithmetic, their food held about 9 to 40,000 times the finasteride level in a man on 1 mg, depending on the comparison (gut or plasma), in an insect with no known version of finasteride's human target enzyme.
What did the finasteride fruit fly study find?
The study mostly used the fruit fly Drosophila melanogaster, with a short mouse behaviour test alongside (Long et al. 2026). In the authors' words, "Finasteride exposure is associated with increased intestinal reactive oxygen species (ROS) accumulation and shortened lifespan in both sexes, together with significantly reduced starvation resistance in males."
Exposed flies also had altered nerve-muscle junctions, weaker climbing and lower expression of the gene cask. Raising CASK in motor neurons improved both the junctions and the climbing. The authors call for the drug's effects to be investigated "in other experimental systems."
The fly food held 0.1, 0.3, 0.5, 0.7 or 1 mM finasteride, and the mechanistic experiments compared 0.7 mM with control food. By our approximate reading of the published survival curves, females on 0.7 and 1 mM reached 50% survival around day 40, against about day 58 for controls. Males separated less from their controls, and we couldn't read the statistics.
The mouse test measured movement, not lifespan. Male mice given 50 mg/kg finasteride covered less distance and entered fewer arms of a Y-shaped maze 45 minutes later than vehicle-treated mice. Judging by the plotted points, there were about five mice per group. The methods are paywalled, so we couldn't see the fly strain, group sizes, solvent, mouse dosing route or statistical tests.
Is the fruit fly dose comparable to a human dose of finasteride?
Not directly. Every rough comparison puts the flies above human exposure, by anywhere from about 9 to about 40,000 times, depending on what you compare. None is exact, because fly tissue levels aren't among the results we could see.
Start with plasma. Finasteride's molecular weight is 372.55 (Organon 2024), so 0.1 mM works out to about 37 mg per litre of food and 0.7 mM to about 261 mg. In a label study of 12 healthy men taking 1 mg a day, peak plasma finasteride at steady state averaged 9.2 ng/mL. By that arithmetic, the fly food ran from about 4,000 times that level at 0.1 mM to about 40,000 times at 1 mM.
Gut oxidative stress was one of the paper's main findings, so gut concentration is a second yardstick. A whole 1 mg tablet dissolved in 250 mL of fluid gives about 4 mg per litre, roughly 0.01 mM. That makes the fly food about 9 times more concentrated at 0.1 mM and about 93 times at 1 mM.
Finasteride is also "practically insoluble in water" (Organon 2024). How it was mixed into the food, and whether the control food carried the same solvent, matter for reading the result.
For the mice, FDA guidance converts a dose by body surface area by dividing mg/kg by 12.3 (FDA 2005). That turns 50 mg/kg into about 4 mg/kg, or roughly 240 mg for the 60 kg adult the guidance assumes. That's about 240 times the 1 mg hair loss dose.
Do fruit flies have the enzyme finasteride blocks?
Probably not. A 2024 survey of the 5-alpha-reductase family across species found three SRD5A1/2 genes in the roundworm C. elegans "but none was found in Drosophila melanogaster" (Ali et al. 2024).
In humans, finasteride blocks type II 5-alpha-reductase, the enzyme that converts testosterone into DHT (Organon 2024). Its effect on hair loss is attributed to lowering DHT, the hormone that grows beards but causes baldness.
Insects also run on a different steroid system. Ecdysone is "the central regulator of insect developmental transitions" (Yamanaka et al. 2013). A 1991 review concluded that "typical vertebrate-type (C21, C19 and C18) steroids probably do not act as physiologically active substances in insects," and testosterone is one of those (Swevers et al. 1991).
So whatever finasteride did to the flies may have gone through a route other than lowering DHT, such as an off-target effect of a high concentration of the molecule. We couldn't read the authors' own discussion of mechanism. The fly result can still be accurate for flies. It answers a separate question from what lowering DHT does in a man.
Does finasteride shorten life in humans?
The largest randomized trial found no significant difference in survival over up to 18 years of follow-up (Thompson et al. 2013). The Prostate Cancer Prevention Trial randomized 18,882 men aged 55 or older to finasteride 5 mg a day or placebo for seven years (Thompson et al. 2003). All had a normal prostate exam and a PSA of 3.0 ng/mL or lower.
The trial's first report found fewer prostate cancers on finasteride but a higher share of high-grade tumours (Thompson et al. 2003). The Propecia label still warns of more Gleason score 8 to 10 cancers in the trial, 1.8% against 1.1% (Organon 2024). The 2013 follow-up set out "to seek any evidence of an increased risk of death among men in the finasteride group." It used the Social Security Death Index through 31 October 2011 (Thompson et al. 2013).
Among the 18,880 men eligible for that analysis, 15-year survival was 78.0% on finasteride against 78.2% on placebo (Thompson et al. 2013). The unadjusted hazard ratio for death on finasteride was 1.02 (95% confidence interval 0.97 to 1.08, P = 0.46). Adjusting for age, race and a prostate cancer diagnosis gave 1.03 (0.98 to 1.09).
That interval is compatible with anything from about 3% lower to 8% higher risk of death. So the trial cannot exclude a small increase, while it makes a large effect on survival unlikely in this population.
What do other human studies show about finasteride and mortality?
The observational studies are mixed. Each groups finasteride and dutasteride together, in mostly older patients.
A Swedish registry followed 349,152 men who had a PSA test, 26,190 of them users (Björnebo et al. 2022). Deaths from any cause did not differ significantly over a median 8.2 years. Adjusted hazard ratios ran from 0.99 (0.94 to 1.05) for up to 2 years of use to 0.97 (0.88 to 1.07) for more than 8 years. Users were older than non-users (median 66 against 57), and the authors lacked data on body mass index, alcohol and tobacco. That leaves room for confounding.
Two other studies found associations with higher mortality. Among 80,875 US veterans with prostate cancer, men who had taken a 5-alpha-reductase inhibitor before diagnosis were diagnosed later, with more advanced disease (Sarkar et al. 2019). Their all-cause mortality was higher too (hazard ratio 1.10, 1.05 to 1.15). The authors linked the findings to the drugs' roughly 50% suppression of PSA delaying diagnosis.
A Korean nested case-control study compared 3,084 deaths with 14,630 matched controls, all with benign prostatic hyperplasia or androgenetic alopecia and an average age of about 69 (Kim et al. 2025). Ever-use was associated with 16.9% higher all-cause mortality (adjusted hazard ratio 1.169, 1.049 to 1.302). That excess was concentrated in people with the lowest cumulative doses. The highest cumulative doses were associated with about half the risk of never-users. Ever-use was also associated with higher suicide mortality, based on 154 suicide deaths. The authors state that causality could not be established with their design.
One study, mainly in mice, looked at cholesterol and plaque (McQueen et al. 2024). Mice bred to develop atherosclerosis had lower cholesterol and slower plaque growth on finasteride. In US survey data, 155 men who reported finasteride use had lower cholesterol than non-users, with dose and duration unknown.
What do regulators say about finasteride's sexual and mood side effects?
The US label lists decreased libido, erectile dysfunction and ejaculation disorder as the most common adverse reactions to finasteride 1 mg. Regulators also list mood changes, including suicidal thoughts.
In the 1-year hair loss trials summarised on the label, 3.8% of men on finasteride 1 mg reported at least one of the three sexual effects, against 2.1% on placebo (Organon 2024). Decreased libido ran 1.8% against 1.3%, erectile dysfunction 1.3% against 0.7%, and ejaculation disorder 1.2% against 0.7%.
The label's postmarketing section adds "sexual dysfunction that continued after discontinuation of treatment," "depression, suicidal ideation and behavior," breast tenderness and enlargement, and male breast cancer. It also warns that because these reports come "from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure." Symptoms that persist after stopping raise their own question: are finasteride and dutasteride irreversible?
In 2025, after an EU-wide review, the European Medicines Agency's safety committee confirmed suicidal ideation "as a side effect of finasteride 1 and 5 mg tablets" (EMA 2025). Its frequency cannot be estimated from available data. The review counted 313 reports of suicidal ideation for finasteride in the EU adverse-event database, against an estimated exposure of around 270 million patient-years. Most were in people taking 1 mg tablets for hair loss.
The EMA's measures, made legally binding in August 2025, include a patient card in packs of 1 mg tablets. Men taking 1 mg are advised to stop treatment and seek medical advice if their mood changes.
The review could not establish a link for dutasteride. The EMA still said information on mood changes would be added to dutasteride's product information as a precaution. The committee concluded that the benefits of both drugs continue to outweigh their risks for approved uses. For the neurosteroid biology behind the mood question, see the three pathways of 5-alpha-reductase.
What we do not know about finasteride and lifespan
In PubMed searches run in November 2026, we found no study of mortality in younger men taking 1 mg for hair loss over decades. The Prostate Cancer Prevention Trial gave 5 mg to men with a median age of 63.2, for seven years. Its survival report is a post hoc analysis "that was not prespecified in the original protocol" (Thompson et al. 2013).
Most of that trial's death data came from the Social Security Death Index, which records no cause of death. Some deaths may have been missed, though the authors saw no reason this would differ between groups. The observational studies cannot fully separate the drugs from the reasons people start and stop them.
As for the flies, we found no replication of the study, we could not read its methods, and our readings of its survival curves are approximate. We also found no human study of its gut and nerve-muscle findings.
Frequently asked questions
Does finasteride shorten your lifespan or life expectancy?
The largest randomized evidence shows no statistically significant difference in survival. In the Prostate Cancer Prevention Trial, men aged 55 and over took finasteride 5 mg or placebo for seven years. Fifteen-year survival was 78.0% against 78.2%. Observational studies are mixed, and we found no mortality study of younger men taking 1 mg for hair loss over decades.
What dose of finasteride did the fruit fly study use?
The flies were kept on food containing 0.1 to 1 mM finasteride, with mechanistic tests at 0.7 mM, about 261 mg per litre. By our arithmetic, even the lowest concentration was about 4,000 times the average peak plasma level in men taking 1 mg a day. That compares food with plasma, though, and fly tissue levels were not reported.
Is finasteride safe long term?
Long-term finasteride data come mainly from older men taking 5 mg. In the Prostate Cancer Prevention Trial, seven years of 5 mg did not significantly change survival over up to 18 years. The Propecia label warns of more high-grade prostate cancers and lists sexual and mood side effects. We found no mortality study of 1 mg in younger men.
Does dutasteride shorten lifespan?
The human mortality data on dutasteride in this article come from observational studies that pool it with finasteride. A Swedish registry of 349,152 men found no significant difference in deaths. A Korean case-control study found higher mortality at low cumulative doses. Dutasteride is used off-label for hair loss in the US.
Can finasteride cause depression or suicidal thoughts?
In 2025 the European Medicines Agency confirmed suicidal ideation as a side effect of finasteride tablets, frequency unknown. It advised men on 1 mg to stop and seek advice if their mood changes. The US Propecia label lists depression and suicidal ideation among postmarketing reports, where it is 'not always possible to reliably estimate their frequency or establish a causal relationship.'
Should I stop finasteride because of the fruit fly study?
The fruit fly study is not direct evidence about human lifespan. It used concentrations above human exposure by every comparison we could make, in an insect with no known version of finasteride's human target enzyme. A randomized trial in men found no significant survival difference. Decisions about stopping finasteride belong with a clinician who knows your history.
References
- Long K, Mo K, Xu K, Yang X, Xu X, Wang S, Rui M. Effects of finasteride exposure on lifespan and locomotor phenotypes. Biogerontology. 2026;27(6):181. DOI: 10.1007/s10522-026-10529-7Cited in What did the finasteride fruit fly study find?
- Swevers L, Lambert JG, De Loof A. Synthesis and metabolism of vertebrate-type steroids by tissues of insects: a critical evaluation. Experientia. 1991;47(7):687-98. DOI: 10.1007/BF01958817Cited in Do fruit flies have the enzyme finasteride blocks?
- Ali K, Li W, Wu G. Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes. Heliyon. 2024;10(14):e34322. DOI: 10.1016/j.heliyon.2024.e34322Cited in Do fruit flies have the enzyme finasteride blocks?
- Yamanaka N, Rewitz KF, O'Connor MB. Ecdysone control of developmental transitions: lessons from Drosophila research. Annu Rev Entomol. 2013;58:497-516. DOI: 10.1146/annurev-ento-120811-153608Cited in Do fruit flies have the enzyme finasteride blocks?
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-24. DOI: 10.1056/NEJMoa030660Cited in Does finasteride shorten life in humans? (2)
- Thompson IM Jr, Goodman PJ, Tangen CM, et al. Long-term survival of participants in the Prostate Cancer Prevention Trial. N Engl J Med. 2013;369(7):603-10. DOI: 10.1056/NEJMoa1215932Cited in Introduction · Does finasteride shorten life in humans? (3) · What we do not know about finasteride and lifespan
- Björnebo L, Nordström T, Discacciati A, et al. Association of 5α-reductase inhibitors with prostate cancer mortality. JAMA Oncol. 2022;8(7):1019-1026. DOI: 10.1001/jamaoncol.2022.1501Cited in What do other human studies show about finasteride and mortality?
- Sarkar RR, Parsons JK, Bryant AK, et al. Association of treatment with 5α-reductase inhibitors with time to diagnosis and mortality in prostate cancer. JAMA Intern Med. 2019;179(6):812-819. DOI: 10.1001/jamainternmed.2019.0280Cited in What do other human studies show about finasteride and mortality?
- Kim J, Jang SY, Park EC. Differential association between cumulative dose of 5α-reductase inhibitors and mortality. Sci Rep. 2025;15(1):10962. DOI: 10.1038/s41598-025-95583-wCited in What do other human studies show about finasteride and mortality?
- McQueen P, Molina D, Pinos I, et al. Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men. J Lipid Res. 2024;65(3):100507. DOI: 10.1016/j.jlr.2024.100507Cited in What do other human studies show about finasteride and mortality?
- Organon LLC. PROPECIA (finasteride) tablets, prescribing information. DailyMed label version effective 14 October 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f904709-65aa-44ce-b144-b4c8a0416e36Cited in Is the fruit fly dose comparable to a human dose of finasteride? (2) · Do fruit flies have the enzyme finasteride blocks? · Does finasteride shorten life in humans? · What do regulators say about finasteride's sexual and mood side effects?
- EMA (European Medicines Agency). Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines. 22 August 2025. EMA/202053/2025. https://www.ema.europa.eu/en/documents/referral/finasteride-dutasteride-containing-medicinal-products-article-31-referral-measures-minimise-risk-suicidal-thoughts_en.pdfCited in What do regulators say about finasteride's sexual and mood side effects?
- FDA (US Food and Drug Administration). Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. July 2005. https://www.fda.gov/media/72309/downloadCited in Is the fruit fly dose comparable to a human dose of finasteride?
This article is for educational purposes only and is not medical advice. Oral finasteride 1 mg is FDA approved for male pattern hair loss and is contraindicated in women who are or may become pregnant; dutasteride and topical finasteride are used off-label for hair loss in the United States, and compounded formulations are not FDA approved. Starting, changing or stopping a prescription drug is a decision to make with a qualified clinician who knows your history. If you are having thoughts of suicide, contact a doctor or, in the US, call or text the 988 Suicide and Crisis Lifeline.


